The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
PerkinElmer has acquired Spectral Genomics, a company focused on developing technology that detects chromosomal abnormalities. (May)
Spectral Genomics, which was established in 2000 by scientists at Baylor College of Medicine, brought in $12.3mm through venture rounds,...